Think Pink: Breast Cancer Awareness

Great post! Thank you for all the information.

I hope you and your site visitors will have the patience to read through this comment, since I realize that it is very long. But I sincerely hope that it you will feel that it adds some important information to the conversation that many women might not have read about before!

I definitely feel very strongly that we women should do everything we can to try to eradicate breast cancer! It’s just that I am not sure that we are going about it in the right way.

Every October, for National Breast Cancer Awareness Month, there’s a huge, multi-organization publicity campaign encouraging women to either buy “pink products” or to get mammograms — or both. So, for one month out of every year, we women work hard to do our parts to participate in activities that we are told will help to eradicate breast cancer.

At least, that’s what we THINK we are doing. It’s what we WANT to be doing.

But, most women don’t know about the POLITICS that surround the entire “Cancer Industry.” (This phrase was coined by Ralph Moss, PhD, with his book of the same name.) This, and many other books, give lots of examples that demonstrate that the cancer industry has political and financial ties with pharmaceutical and chemical companies — the very companies that benefit most from the chemotherapy that is given to treat cancer. (Pharmaceutical companies benefit because they provide the cancer treatments. Chemical companies benefit because they may actually be causing the cancers, as several books point out — including Samuel Epstein, MD’s “The Politics of Cancer (1978, 1998); and two books published in 2007: “Cancer: 101 Solutions to a Preventable Epidemic,” by Liz Armstrong, Guy Dauncey, and Anne Wordsworth; and “The Secret History of the War on Cancer,” by Dr. Devra Lee Davis.)

The Breast Cancer Industry is fraught with such ties. For instance, did you know that the American Cancer Society receives many donations from big pharmaceutical companies – for instance, AstraZeneca’s $10 million donation, earlier this year? (Both Arimidex and Tamoxifen were developed by, and are distributed by, AstraZeneca!)

There are also political connections. For instance, when you buy pink products, with part of the money going to the Susan G. Koman Foundation, are you aware that Nancy Brinker, the founder of the organization, has heavy ties to the Republican Party, and was named by George W. Bush to a US Ambassadorship? (She was also on governmental panels during the three most recent Republican presidents. These facts may not bother you at all — but they may.)

Whether or not you are bothered by Ms. Brinker’s Republican Party connections, I am quite sure that most women will be upset to learn that “the Komen Foundation helped block a meaningful Patients Bill of Rights for the women it has purported to serve since the group began in 1982.” (Please read Mary Ann Swissler’s article, “The Marketing of Breast Cancer” at http://www.alternet.org/story/14014/?page=entire.)

Numerous articles have been written about the politics and financial ties surrounding many National Breast Cancer Awareness Month activities. Several articles have been collected and posted on the thinkbeforeyoupink.org website. (“Think Before You Pink” is a project of “Breast Cancer Action,” an organization that advocates concentrating our research dollars on prevention, rather than treatment, and states in its annual report that it does not accept any funds from “pharmaceutical, biotechnology, or chemical companies, or any other entities that profit from or contribute to the breast cancer epidemic.”) Another organization with a similar agenda is the National Breast Cancer Coalition.

There are also lots of articles on the Cancer Industry on my website, http://www.HonestMedicine.com.

These are the on-the-surface financial concerns — the fact that these organizations have financial ties to the very organizations that benefit from their work.

But more recently, another concern has been raised — a concern that is NOT at all being addressed by these organizations:

IS EARLY DETECTION WITH MAMMOGRAMS REALLY THE BEST WAY TO SAVE LIVES?

Several recent articles say that no, early detection with mammograms is NOT the best approach to treating breast cancer.

One of the most vocal, and highest profile, journalists to write about this is Shannon Brownlee, author of the recent excellent, and controversial, book, “Overtreated: Why Too Much Medicine is Making Us Sicker and Poorer.” Her point is that Americans are being over-scanned, over-surgeried, and just plain over-treated, by our medical system, and that, in many cases, this over-treatment results in worse outcomes. This, and a book called “Money Driven Medicine: The Real Reason Health Care Costs So Much,” by Maggie Mahar, are two very important books; I urge everyone to read both.

Ms. Brownlee addressed the mammogram issue BEFORE the publication of her book, in a 2002 “New Republic” cover story, “Search and Destroy: Why Mammograms Are Not the Answer.” Her main point in this excellent article — and she uses numerous credible resources to back up her position — is that mammograms, in addition to being moneymakers for the institutions that provide them, are the first step toward a huge cash cow these hospitals will enjoy when their mammograms discover breast cancers: chemotherapy, radiation, surgery, etc.

But, as if this weren’t bad enough, it turns out that mammograms may be detecting more of the tiny cancers, which might never have bothered women had they not been detected so early, and fewer of the aggressive cancers that kill. In other words, mammograms may actually be doing more harm than good, by subjecting some women with potentially harmless tumors to potentially harmful treatments — surgery, chemotherapy and radiation.

But the best part about Shannon Brownlee is that she doesn’t just criticize. She has a solution, too, which is to concentrate our research dollars on finding ways to tell whether a cancer is — or isn’t — the kind that will eventually kill a woman later on, so that doctors will not operate on all women with the tiniest (and least cancerous) of growths, telling them, “Boy, are you lucky we caught this so early!” (Well, maybe yes, and maybe no.)

So, maybe it’s time that the “think pink” companies and organizations look to avenues other than recommending that women buy products and get mammograms.

I realize that I have included many resources in this comment. For those who would like to access the links, I have posted the text of this comment — complete with hyperlinks to each and every resource — on my website. (See “National Breast Cancer Awareness Month — Honest Medicine’s Julia Schopick Responds to Sen. Joe Biden,” on my site.)

Thank you so much.
Julia Schopick
http://www.HonestMedicine.com